Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.1K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

4.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.6K
Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

75.8K
Oxidation–Reduction Reactions
75.8K
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.1K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.1K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

699
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
699

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stakeholder Perspectives on Long-Acting Injectable PrEP and MOUD: A Descriptive Qualitative Study.

medRxiv : the preprint server for health sciences·2026
Same author

Assessment of Attitudes, Barriers, and Facilitators of Pre-exposure Prophylaxis (PrEP) Use Among Individuals Involved in the Criminal Legal System in the Southern U.S.

AIDS education and prevention : official publication of the International Society for AIDS Education·2026
Same author

"You feel like you going to die:" The intersection of mass incarceration and climate disasters.

SSM. Qualitative research in health·2026
Same author

Criminalizing Serious Mental Illness: What Linked Urban Data Reveal and the Case for Community Care.

Journal of urban health : bulletin of the New York Academy of Medicine·2026
Same author

Lagged and non-linear effects of temperature extremes on mortality in US federal prisons: a case-crossover study, 2009-2021.

Epidemiology (Cambridge, Mass.)·2026
Same author

Evaluating Crowdsourced Data Collection for Carceral Death Surveillance: Pilot Study Using Amazon Mechanical Turk.

JMIR formative research·2026

Related Experiment Video

Updated: Feb 10, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

12.7K

Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk.

Lauren Brinkley-Rubinstein1,2, David Cloud3,4, Ernest Drucker5

  • 1Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA. Lauren_Brinkley@med.unc.edu.

Current HIV/AIDS Reports
|May 13, 2018
PubMed
Summary

This review highlights harm reduction strategies for individuals with criminal justice experience facing HIV and opioid risks. Key interventions include medication-assisted treatment and syringe services programs within correctional settings.

Keywords:
Criminal justice experienceHIVHarm reductionOpioid useSafe injection facilitiesSyringe exchange programs

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K

Related Experiment Videos

Last Updated: Feb 10, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
13:50

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients

Published on: June 11, 2011

12.7K
High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.4K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Addiction Medicine

Background:

  • The opioid epidemic has surged, increasing HIV risk among people who inject drugs.
  • Rural jails are central to the opioid epidemic, impacting incarcerated populations.
  • Individuals with criminal justice experience are a vulnerable group for HIV and opioid use.

Purpose of the Study:

  • To review harm reduction strategies for individuals with criminal justice experience.
  • To identify interventions applicable in correctional settings for HIV and opioid use.

Main Methods:

  • Literature review of HIV and opioid research.
  • Focus on harm reduction within the criminal justice system.

Main Results:

  • Harm reduction strategies can be implemented in correctional settings.
  • Key strategies include medication-assisted treatment (MAT), syringe exchange programs (SEPs), and safe injection facilities (SIFs).
  • Pre-exposure prophylaxis (PrEP) can be repackaged as a harm reduction tool.

Conclusions:

  • Implementing harm reduction in correctional settings is crucial for public health.
  • These strategies can mitigate HIV and opioid-related harms in a high-risk population.
  • Tailored interventions are needed for individuals transitioning from the criminal justice system.